Edgewell Q4 net sales $534M (-0.5% YoY); FY23 adj EPS $2.56 (+14% CC); FY24 guides 2-4% organic growth

EDGEWELL PERSONAL CARE Co

2023-FY EPS reported $2.21 revenue$2,251,600,000

GAAP diluted EPS Q4 $0.57, FY23 $2.18; adjusted EPS Q4 $0.72, FY23 $2.56 (up 14% constant currency YoY).
Full year organic net sales growth of 4.3%; Q4 organic sales declined 1.9%.
Returned $107M to shareholders via $75M buybacks and $32M in dividends; net debt leverage 3.4x.
Board declared quarterly cash dividend of $0.15 per share on November 2, 2023.
FY2024 outlook: organic net sales growth ~2-4%, adjusted EPS growth ~7% (15% constant currency).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

EDGEWELL PERSONAL CARE Co reported fourth quarter and fiscal year ended September 30, 2023 results: revenue $534.1 million, EPS $0.57. Guidance initiated.

Period: fourth quarter and fiscal year ended September 30, 2023
Revenue: $534.1 million
EPS: $0.57
Guidance: initiated
Result: reported results

Exact text from the filing

its fourth fiscal quarter 2023 and fiscal year ended, September 30, 2023 , and provided its financial outlook for fiscal 2024 . Executive Summary • Fourth quarter net sales were $534.1 million, a decrease of 0.5% compared to the prior year period. Full year net sales were $2,251.6 million, an increase of 3.7% compared to the prior year. • Organic net sales decreased

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

EDGEWELL PERSONAL CARE Co filing history →

Source: SEC EDGAR

accession 0001628280-23-038014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.